BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 17060161)

  • 1. Defining the roles of Asn-128, Glu-129 and Phe-130 in loop A of the 5-HT3 receptor.
    Sullivan NL; Thompson AJ; Price KL; Lummis SC
    Mol Membr Biol; 2006; 23(5):442-51. PubMed ID: 17060161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A hydrogen bond in loop A is critical for the binding and function of the 5-HT3 receptor.
    Price KL; Bower KS; Thompson AJ; Lester HA; Dougherty DA; Lummis SC
    Biochemistry; 2008 Jun; 47(24):6370-7. PubMed ID: 18498149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locating an antagonist in the 5-HT3 receptor binding site using modeling and radioligand binding.
    Thompson AJ; Price KL; Reeves DC; Chan SL; Chau PL; Lummis SC
    J Biol Chem; 2005 May; 280(21):20476-82. PubMed ID: 15781467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of tyrosine residues in the extracellular domain of the 5-hydroxytryptamine3 receptor.
    Price KL; Lummis SC
    J Biol Chem; 2004 May; 279(22):23294-301. PubMed ID: 14998995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
    Lochner M; Lummis SC
    Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loop B is a major structural component of the 5-HT3 receptor.
    Thompson AJ; Lochner M; Lummis SC
    Biophys J; 2008 Dec; 95(12):5728-36. PubMed ID: 18931259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.
    Suryanarayanan A; Joshi PR; Bikádi Z; Mani M; Kulkarni TR; Gaines C; Schulte MK
    Biochemistry; 2005 Jun; 44(25):9140-9. PubMed ID: 15966738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varenicline Interactions at the 5-HT3 Receptor Ligand Binding Site are Revealed by 5-HTBP.
    Price KL; Lillestol RK; Ulens C; Lummis SC
    ACS Chem Neurosci; 2015 Jul; 6(7):1151-7. PubMed ID: 25648658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.
    Nyce HL; Stober ST; Abrams CF; White MM
    Biophys J; 2010 May; 98(9):1847-55. PubMed ID: 20441748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational Changes in the 5-HT
    Munro L; Ladefoged LK; Padmanathan V; Andersen S; Schiøtt B; Kristensen AS
    Mol Pharmacol; 2019 Dec; 96(6):720-734. PubMed ID: 31582575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of 5-HT3 receptor mutations identified in schizophrenic patients.
    Thompson AJ; Sullivan NL; Lummis SC
    J Mol Neurosci; 2006; 30(3):273-81. PubMed ID: 17401153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the ligand-binding site of the serotonin 5-HT3 receptor: the role of glutamate residues 97, 224, AND 235.
    Schreiter C; Hovius R; Costioli M; Pick H; Kellenberger S; Schild L; Vogel H
    J Biol Chem; 2003 Jun; 278(25):22709-16. PubMed ID: 12660235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding orientations of structurally-related ligands can differ; A cautionary note.
    Ruepp MD; Wei H; Leuenberger M; Lochner M; Thompson AJ
    Neuropharmacology; 2017 Jun; 119():48-61. PubMed ID: 28137449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unbinding pathways of an agonist and an antagonist from the 5-HT3 receptor.
    Thompson AJ; Chau PL; Chan SL; Lummis SC
    Biophys J; 2006 Mar; 90(6):1979-91. PubMed ID: 16387779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT(3) receptors.
    Lummis SC
    J Biol Chem; 2012 Nov; 287(48):40239-45. PubMed ID: 23038271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring a potential palonosetron allosteric binding site in the 5-HT(3) receptor.
    Del Cadia M; De Rienzo F; Weston DA; Thompson AJ; Menziani MC; Lummis SC
    Bioorg Med Chem; 2013 Dec; 21(23):7523-8. PubMed ID: 24128813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palonosetron-5-HT
    Price KL; Lillestol RK; Ulens C; Lummis SC
    ACS Chem Neurosci; 2016 Dec; 7(12):1641-1646. PubMed ID: 27656911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis and molecular modeling reveal the importance of the 5-HT3 receptor F-loop.
    Thompson AJ; Padgett CL; Lummis SC
    J Biol Chem; 2006 Jun; 281(24):16576-82. PubMed ID: 16595668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tyrosine residues that control binding and gating in the 5-hydroxytryptamine3 receptor revealed by unnatural amino acid mutagenesis.
    Beene DL; Price KL; Lester HA; Dougherty DA; Lummis SC
    J Neurosci; 2004 Oct; 24(41):9097-104. PubMed ID: 15483128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.